The US Centers for Disease Control temporarily paused more than 24 types of laboratory tests, reportedly because of a routine review.

Former US Surgeon General Dr Jerome Adams has joined others in criticizing President Donald Trump’s nominee for the role, Dr Casey Means.

Intermittent tacrolimus after dupilumab discontinuation in patients with AD was associated with longer time to disease flare than on-demand therapy.

Phase 3 studies showed zasocitinib, a highly selective oral tyrosine kinase 2 inhibitor, provided rapid, durable skin improvement.

Adult acne is affected by sedentary behavior, exercise, and sleep, with depression and anxiety having a significant effect on this relationship.

Tralokinumab is effective and safe for the treatment of patients with moderate to severe AD through 6 total years of treatment.

A new vaccine from companies Pfizer and Valneva meant to prevent Lyme disease may be one step closer to approval.

The FDA accepts a New Drug Application for bezuclastinib to treat nonadvanced systemic mastocytosis based on positive data from the SUMMIT trial.

Patients with dermatomyositis in the US experience substantial variability in treatment, high glucocorticoid exposure, and significant healthcare utilization.

Acne is a common and clinically relevant adverse event among patients with IBD receiving JAK inhibitors. Acne occurs in 8.6% of individuals with inflammatory bowel diseases (IBD) who are receiving ...

Later onset of vitiligo in patients with melanoma who initiated anti-PD-1 therapy was associated with a lower 3-year ...

Nicotinamide supplementation has shown promising effectiveness in melanoma prevention, according to poster results from the ...